Retinal Degeneration Fund

Raleigh, United States
Investments are focused on retinal degeneration therapeutic solutions.

About Retinal Degeneration Fund

Retinal Degeneration Fund is a Healthcare company based in Raleigh (United States). Investments are focused on retinal degeneration therapeutic solutions. It operates on a HealthTech model. Retinal Degeneration Fund offers products and services including Investment in Retinal Therapies. Its focus areas include Biotechnology and Ophthalmology.

Company details

The Retinal Degeneration Fund is dedicated to accelerating life-changing outcomes for individuals with retinal degenerative diseases. Investments are made directly in therapeutic companies working on preventions, treatments, and cures for conditions such as retinitis pigmentosa, age-related macular degeneration, and Usher syndrome. The focus is placed on the healthcare sector, specifically ophthalmology, to address blinding conditions affecting over 200 million people worldwide. Support is provided through mission-related investments to drive research and development in this critical area.

Operational Areas

Products & Services of Retinal Degeneration Fund

Retinal Degeneration Fund offers a comprehensive portfolio of products and services, including Investment in Retinal Therapies.

Investment in Retinal Therapies
Healthcare Investment

Investments are made in retinal degeneration therapeutic companies.

Top companies in Ophthalmology

3 companies that operate in the same segment as Retinal Degeneration Fund (Ophthalmology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of a wide range of eye care products
1945Fort Worth, Texas, United StatesUSD 171.61 MUSD 24.69 B25,941
Genetic medicines are developed by 4DMT for transformative therapies.
2013Emeryville, California, United StatesUSD 186.59 MUSD 85.21 M227
Developer of antibodies to treat complement-mediated neurodegenerative diseases
2011San Francisco, California, United StatesUSD 256 M100
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Retinal Degeneration Fund

Retinal Degeneration Fund is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.

The Retinal Degeneration Fund is dedicated to accelerating life-changing outcomes for individuals with retinal degenerative diseases. Investments are made directly in therapeutic companies working on preventions, treatments, and cures for conditions such as retinitis pigmentosa, age-related macular degeneration, and Usher syndrome. The focus is placed on the healthcare sector, specifically ophthalmology, to address blinding conditions affecting over 200 million people worldwide. Support is provided through mission-related investments to drive research and development in this critical area.

Retinal Degeneration Fund offers Investment in Retinal Therapies.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available